CAMP4 Therapeutics
CAMP
NASDAQ
IPO2024
about CAMP
CAMP4 Therapeutics develops innovative cancer treatments using mRNA-based immunotherapies and personalized vaccines designed to advance new approaches for treating cancer.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.19 | $7.75 | $4.19 | $217.90M | 5.92M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.55 | n/a | 227.80 | -1717.11% | -1899.25% | 0% |